{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:42:18Z","timestamp":1793418138980,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013899","name":"M.S.I. Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004428","name":"Ministry of Land and Resources of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006441","name":"Center for Outcomes Research and Evaluation, Yale School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006441","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.cancergen.2019.10.005","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T18:52:41Z","timestamp":1571683961000},"page":"5-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["High-resolution copy number analysis of clear cell endometrial carcinoma"],"prefix":"10.1016","volume":"240","author":[{"given":"Andrea J.","family":"O'Hara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Le Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan L.","family":"Rudd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne W.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2019.10.005_bib0001","first-page":"1","article-title":"Cancer facts and figures","volume":"1","year":"2018","journal-title":"Am Cancer Society"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0002","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrclinonc.2010.216","article-title":"Emerging therapeutic targets in endometrial cancer","volume":"8","author":"Dedes","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0003","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00125480-200405000-00001","article-title":"Non-endometrioid carcinomas of the uterine corpus: a review of their pathology with emphasis on recent advances and problematic aspects","volume":"11","author":"Clement","year":"2004","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0004","series-title":"Patient and tumor characteristics","first-page":"1988","article-title":"SEER survival monograph: cancer survival among adults: U.S. SEER program","author":"Ries","year":"2007"},{"issue":"Suppl 1","key":"10.1016\/j.cancergen.2019.10.005_bib0005","first-page":"S105","article-title":"Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0006","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/IGC.0000000000000844","article-title":"Survival differences among uterine papillary serous, clear cell and grade 3 endometrioid adenocarcinoma endometrial cancers: a National Cancer Database analysis","volume":"27","author":"McGunigal","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0007","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/sj.bjc.6603012","article-title":"Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers","volume":"94","author":"Hamilton","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0008","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-3-319-43139-0_4","article-title":"Traditional approaches to molecular genetic analysis","volume":"943","author":"Walker","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0009","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-3-319-43139-0_5","article-title":"Next-generation sequencing","volume":"943","author":"Le Gallo","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0011","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1016\/S1470-2045(13)70591-6","article-title":"Classification of endometrial carcinoma: more than two types","volume":"15","author":"Murali","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0012","series-title":"Precision molecular pathology of uterine cancer","first-page":"87","article-title":"Molecular pathology of serous carcinoma","author":"Urick","year":"2017"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0013","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/modpathol.3800057","article-title":"Molecular characterization of uterine clear cell carcinoma","volume":"17","author":"An","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0014","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/modpathol.2014.93","article-title":"Molecular alterations in endometrial and ovarian clear cell carcinomas: clinical impacts of telomerase reverse transcriptase promoter mutation","volume":"28","author":"Huang","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0015","first-page":"166","article-title":"Targeted mutation analysis of endometrial clear cell carcinoma","volume":"40","author":"Hoang","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0016","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1158\/1078-0432.CCR-10-0540","article-title":"A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas","volume":"17","author":"Rudd","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0017","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1158\/0008-5472.CAN-11-0549","article-title":"PIK3R1 (p85alpha) is somatically mutated at high frequency in primary endometrial cancer","volume":"71","author":"Urick","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0018","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng.2455","article-title":"Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes","volume":"44","author":"Le Gallo","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0019","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1002\/cncr.30745","article-title":"Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing","volume":"123","author":"Le Gallo","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0020","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/path.4947","article-title":"The genetic landscape of endometrial clear cell carcinomas","volume":"243","author":"DeLair","year":"2017","journal-title":"J Pathol"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0021","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/modpathol.2015.43","article-title":"Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative","volume":"28","author":"Stelloo","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0022","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s004390050565","article-title":"Frequent gains on chromosome arms 1q and\/or 8q in human endometrial cancer","volume":"100","author":"Suzuki","year":"1997","journal-title":"Hum Genet"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0023","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/gcc.20038","article-title":"Genomic aberrations in carcinomas of the uterine corpus","volume":"40","author":"Micci","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0024","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0165-4608(94)00171-7","article-title":"Near-diploid karyotypes with recurrent chromosome abnormalities characterize early-stage endometrial cancer","volume":"80","author":"Bardi","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0025","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/ng.3602","article-title":"The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis","volume":"48","author":"Gibson","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0026","doi-asserted-by":"crossref","first-page":"20007","DOI":"10.1073\/pnas.0710052104","article-title":"Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma","volume":"104","author":"Beroukhim","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0027","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ng.3016","article-title":"A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors","volume":"46","author":"Petrini","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0028","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1158\/1078-0432.CCR-18-0412","article-title":"Clinical utility of prospective molecular characterization in advanced endometrial cancer","volume":"24","author":"Soumerai","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0029","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ccell.2018.03.014","article-title":"A comprehensive pan-cancer molecular study of gynecologic and breast cancers","volume":"33","author":"Berger","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0030","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0031","first-page":"6","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0032","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1186\/1471-2407-14-884","article-title":"Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1","volume":"14","author":"Rudd","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0033","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0034","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1097\/IGC.0000000000000297","article-title":"Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix","volume":"24","author":"Hasegawa","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0035","first-page":"892","article-title":"Distinct chromosomal imbalances in uterine serous and endometrioid carcinomas","volume":"58","author":"Pere","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0036","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1222577110","article-title":"Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma","volume":"110","author":"Zhao","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1016\/j.cancergen.2019.10.005_bib0037","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/path.4056","article-title":"Use of mutation profiles to refine the classification of endometrial carcinomas","volume":"228","author":"McConechy","year":"2012","journal-title":"J Pathol"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0038","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/jnci\/djs345","article-title":"Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses","volume":"104","author":"Kuhn","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0039","first-page":"177","article-title":"p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis","volume":"150","author":"Tashiro","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0040","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<814::AID-CNCR12>3.0.CO;2-U","article-title":"The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways","volume":"88","author":"Lax","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0041","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/PAS.0b013e31827f576a","article-title":"Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma","volume":"37","author":"Gilks","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.cancergen.2019.10.005_bib0042","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/PGP.0000000000000491","article-title":"High-grade endometrial carcinomas: morphologic and immunohistochemical features, diagnostic challenges and recommendations","volume":"38","author":"Murali","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0043","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1002\/cncr.26598","article-title":"Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma","volume":"118","author":"Rahman","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0044","doi-asserted-by":"crossref","first-page":"836","DOI":"10.5858\/arpa.2015-0220-OA","article-title":"Interobserver variability in the diagnosis of uterine high-grade endometrioid carcinoma","volume":"140","author":"Thomas","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PGP.0000000000000162","article-title":"Endometrial carcinomas with clear cells: a study of a heterogeneous group of tumors including interobserver variability, mutation analysis, and immunohistochemistry with HNF-1beta","volume":"34","author":"Han","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0046","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/PAS.0b013e31825dd4b3","article-title":"The diagnosis of endometrial carcinomas with clear cells by gynecologic pathologists: an assessment of interobserver variability and associated morphologic features","volume":"36","author":"Fadare","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0047","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/modpathol.2013.102","article-title":"Reproducibility of histological cell type in high-grade endometrial carcinoma","volume":"26","author":"Han","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergen.2019.10.005_bib0048","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/jcp.2009.071225","article-title":"Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type","volume":"63","author":"Clarke","year":"2010","journal-title":"J Clin Pathol"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776218304514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776218304514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:42:54Z","timestamp":1761896574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776218304514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":48,"alternative-id":["S2210776218304514"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2019.10.005","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-resolution copy number analysis of clear cell endometrial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2019.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}